tiprankstipranks
Trending News
More News >
Sincere Co. LTD. (JP:7782)
:7782
Japanese Market
Advertisement

Sincere Co. LTD. (7782) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7782

Sincere Co. LTD.

(7782)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 4o)
Rating:73Outperform
Price Target:
¥648.00
▲(13.49% Upside)
Sincere Co. LTD. is well-positioned within the medical instruments industry, with strong financial performance being the most significant factor. The company's stable balance sheet and robust cash flow generation support future growth. While technical indicators suggest a lack of strong momentum, the stock's reasonable valuation and dividend yield enhance its appeal. The absence of earnings call data and corporate events does not impact the overall score.

Sincere Co. LTD. (7782) vs. iShares MSCI Japan ETF (EWJ)

Sincere Co. LTD. Business Overview & Revenue Model

Company DescriptionSincere Co. LTD. (7782) is a diversified company primarily engaged in the manufacturing and distribution of consumer goods, with a focus on high-quality personal care products and household items. Operating in the consumer products sector, Sincere Co. combines innovation and sustainability to deliver a range of products that cater to the evolving needs of consumers. The company emphasizes research and development to enhance its product offerings and maintain a competitive edge in the market.
How the Company Makes MoneySincere Co. generates revenue through multiple streams, including direct sales of its personal care and household products through retail channels and e-commerce platforms. Key revenue streams include wholesale distribution to supermarkets and specialty stores, as well as direct-to-consumer sales via its own online storefront. The company also explores strategic partnerships with retailers and e-commerce platforms to expand its market reach. Additionally, Sincere Co. invests in marketing and promotional campaigns to drive brand awareness and consumer engagement, further contributing to its earnings.

Sincere Co. LTD. Financial Statement Overview

Summary
Sincere Co. LTD. demonstrates solid financial health with strong revenue growth and improved profitability margins. The balance sheet is stable with manageable leverage, and cash flow generation is robust, supporting future growth and investment. While profitability margins are improving, further enhancement could strengthen the company's financial position.
Income Statement
85
Very Positive
Sincere Co. LTD. shows strong performance with an increasing revenue trend, achieving a 9.68% growth from 2023 to 2024. The gross profit margin improved from 30.91% in 2023 to 32.06% in 2024, indicating effective cost management. The net profit margin is stable at around 4.6%, and both EBIT and EBITDA margins have improved, reflecting operational efficiency. However, the relatively modest net profit margin suggests room for improvement.
Balance Sheet
78
Positive
The company maintains a solid financial position with a debt-to-equity ratio of 0.76 in 2024, reflecting a balanced leverage approach. The equity ratio stands at 49.07%, indicating strong equity financing. Return on Equity is stable at 11.16%, demonstrating consistent returns to shareholders. The company's overall balance sheet health is sound, but there is a slight decrease in cash reserves, warranting attention.
Cash Flow
81
Very Positive
Cash flow generation is strong with a significant increase in free cash flow by 90.7% from 2023 to 2024. The operating cash flow to net income ratio of 1.45 indicates robust cash generation relative to profits. The free cash flow to net income ratio of 1.36 highlights effective cash management, supporting continued investment and debt servicing. The company shows resilience in generating cash, despite fluctuations in investing and financing activities.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue7.00B6.54B5.96B5.59B4.56B4.19B
Gross Profit2.31B2.10B1.84B1.40B1.38B1.33B
EBITDA649.32M565.19M469.65M129.00M134.31M232.66M
Net Income376.80M301.75M295.00M66.07M83.93M142.33M
Balance Sheet
Total Assets5.40B5.50B5.40B3.58B3.29B2.90B
Cash, Cash Equivalents and Short-Term Investments1.66B1.89B2.19B1.13B1.09B1.16B
Total Debt1.94B2.05B2.30B1.10B735.00M395.00M
Total Liabilities2.71B2.80B2.92B1.59B1.25B929.26M
Stockholders Equity2.69B2.70B2.41B1.99B2.04B1.97B
Cash Flow
Free Cash Flow0.00403.80M215.00M-313.83M-456.71M253.63M
Operating Cash Flow0.00435.07M246.00M-307.99M-423.60M262.62M
Investing Cash Flow0.00-421.47M-376.00M-28.57M75.70M-60.48M
Financing Cash Flow0.00-332.69M1.18B330.52M258.50M-74.79M

Sincere Co. LTD. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price571.00
Price Trends
50DMA
571.38
Negative
100DMA
575.68
Negative
200DMA
573.72
Negative
Market Momentum
MACD
-9.14
Positive
RSI
38.65
Neutral
STOCH
27.70
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7782, the sentiment is Negative. The current price of 571 is above the 20-day moving average (MA) of 554.20, below the 50-day MA of 571.38, and below the 200-day MA of 573.72, indicating a bearish trend. The MACD of -9.14 indicates Positive momentum. The RSI at 38.65 is Neutral, neither overbought nor oversold. The STOCH value of 27.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7782.

Sincere Co. LTD. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
¥5.65B8.481.90%5.45%0.23%
73
Outperform
¥3.40B9.252.21%16.73%66.79%
69
Neutral
¥2.83B14.642.15%31.86%194.85%
69
Neutral
¥5.08B8.742.63%3.14%-2.85%
67
Neutral
¥17.61B15.802.60%0.81%-26.76%
54
Neutral
¥10.41B66.463.99%0.38%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7782
Sincere Co. LTD.
543.00
74.69
15.95%
JP:4556
Kainos Laboratories, Inc.
1,254.00
71.62
6.06%
JP:7702
JMS Co., Ltd.
433.00
-3.86
-0.88%
JP:7743
Seed Co., Ltd.
553.00
78.86
16.63%
JP:7813
PLATZ Co., Ltd.
838.00
231.30
38.12%
JP:7980
Shigematsu Works Co., Ltd.
786.00
-9.27
-1.17%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 11, 2025